Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
7,980.00
-50.00 (-0.62%)
Mar 20, 2026, 3:30 PM KST
-12.69% (1Y)
| Market Cap | 185.59B -13.4% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 121,662 |
| Average Volume | 205,173 |
| Open | 8,030.00 |
| Previous Close | 8,030.00 |
| Day's Range | 7,980.00 - 8,210.00 |
| 52-Week Range | 6,970.00 - 12,670.00 |
| Beta | 0.89 |
| RSI | 38.76 |
| Earnings Date | Nov 11, 2025 |